Question: What does the FDA do when a new potential blockbuster drug poses a significant risk for heart failure?
Answer: It removes the lead scientist from the drug’s approval process to silence the problem.

Such is the case with Avandia, the 3 billion-a-year blockbuster diabetes drug. And now that the strategy has backfired and blown up in the FDA’s face, only one conclusion is possible: FDA management is intentionally killing Americans and is criminally negligent. Senator Charles Grassley (R-IA) is one of the only men left standing in our equally corrupt Congress.